Voyager Therapeutics, Inc. (VYGR)

Voyager Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	45.13	71.37	68.8	98.96	117.43	104.44
Short-Term Investments	163.81	195.32	162.07	19.89	15.11	76.7
Cash & Short-Term Investments	208.93	266.68	230.88	118.85	132.54	181.14
Cash Growth	-39.50%	15.51%	94.26%	-10.33%	-26.83%	-35.66%
Accounts Receivable	4.04	2.18	83.49	0.26	0.73	8.01
Other Receivables	-	2.31	0.96	0.38	0.02	0.1
Receivables	4.04	4.49	84.46	0.64	0.75	8.11
Prepaid Expenses	6.62	0.43	0.61	0.7	1.36	1.46
Other Current Assets	-	5.21	3.75	4.32	2.05	7.07
Total Current Assets	219.59	276.81	319.68	124.5	136.7	197.77
Property, Plant & Equipment	43.03	47.66	30	33.34	55.38	61.5
Long-Term Investments	20.08	65.7	-	-	-	-
Other Long-Term Assets	5.61	2.87	1.59	1.52	1.78	2.32
Total Assets	288.31	393.05	351.28	159.36	193.86	261.58
Accounts Payable	2.12	4	1.6	2.57	0.57	0.63
Accrued Expenses	14.95	14.17	16.82	7.82	10.95	14.21
Current Portion of Leases	7.85	7.23	3.2	2.83	5.57	4.2
Current Unearned Revenue	10.58	24.39	42.88	59.38	33.89	7.73
Total Current Liabilities	35.5	49.79	64.51	72.59	50.98	26.77
Long-Term Leases	30.52	36.5	17.09	20.29	38.61	43.41
Long-Term Unearned Revenue	1.47	6	32.36	6.45	8.21	36.09
Other Long-Term Liabilities	1	1	1	1	1	1
Total Liabilities	68.49	93.29	114.96	100.34	98.8	107.26
Common Stock	0.06	0.06	0.04	0.04	0.04	0.04
Additional Paid-In Capital	638.24	626.3	497.51	452.71	442.26	430.32
Retained Earnings	-418.48	-326.18	-261.18	-393.51	-347.1	-275.91
Comprehensive Income & Other	0.01	-0.41	-0.05	-0.22	-0.14	-0.13
Total Common Equity	219.83	299.76	236.32	59.02	95.06	154.32
Shareholders' Equity	219.83	299.76	236.32	59.02	95.06	154.32
Total Liabilities & Equity	288.31	393.05	351.28	159.36	193.86	261.58
Total Debt	38.37	43.73	20.29	23.13	44.18	47.61
Net Cash (Debt)	190.64	288.66	210.58	95.72	88.36	133.53
Net Cash Growth	-36.45%	37.08%	119.99%	8.33%	-33.83%	-46.43%
Net Cash Per Share	3.26	5.01	4.72	2.50	2.35	3.58
Filing Date Shares Outstanding	55.6	55.21	54.3	43.29	38.11	37.65
Total Common Shares Outstanding	55.48	54.73	44.04	38.61	37.92	37.37
Working Capital	184.09	227.02	255.18	51.91	85.72	171
Book Value Per Share	3.96	5.48	5.37	1.53	2.51	4.13
Tangible Book Value	219.83	299.76	236.32	59.02	95.06	154.32
Tangible Book Value Per Share	3.96	5.48	5.37	1.53	2.51	4.13
Machinery	-	22.67	23.16	22.01	21.91	20.5
Construction In Progress	-	-	-	-	-	0.87
Leasehold Improvements	-	6.49	7.11	12.55	15.7	15.47

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q